Sequential, a leader in genomic testing from non-invasive human clinical samples, today announced the successful close of its first equity round, securing $3.5 million. The round was co-led by ...

Founded in 2019, Sequential has developed an extensive B2B platform to conduct research on personal care products through microbiome testing, and biophysical assessments. Dr Oliver Worsley, Petronille ...

Phase II Study of Afatinib in Patients With Tumors With Human Epidermal Growth Factor Receptor 2–Activating Mutations: Results From the National Cancer Institute–Molecular Analysis for Therapy Choice ...